SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- George E Peoples, MD, FACS
Cancer Insight, LLC
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Joseph Heritage Healthcare
Santa Rosa, California, United States
- University of Miami/sylvester at Plantation
Plantation, Florida, United States
- Cancer Center of Kansas (cck)
Wichita, Kansas, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- Providence Regional Medical Center
Everett, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 May 2017
- Primary completion
- 22 Nov 2018
- Completion
- 22 Nov 2018
- Last update posted
- 29 Jan 2021
- Registered enrollment
- 24
- Registry id
- NCT03066947
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.